EPISODE · Jun 27, 2019 · 25 MIN
Episode 69: The future of AbbVieGan, the dogma of amyloid, & some questionable biotech marketing
from The Readout Loud · host STAT
Can Botox make Big Pharma attractive? What qualifies as a "cabal"? And will the CRISPR patent fight outlive us all?
Embed this episode
Ready to play
Episode 69: The future of AbbVieGan, the dogma of amyloid, & some questionable biotech marketing
0:00
25:31
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of The Readout Loud?
This episode is 25 minutes long.
When was this The Readout Loud episode published?
This episode was published on June 27, 2019.
Can I download this The Readout Loud episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!